157 related articles for article (PubMed ID: 6171038)
1. Radionuclide imaging of soft tissue neoplasms.
Chew FS; Hudson TM; Enneking WF
Semin Nucl Med; 1981 Oct; 11(4):266-76. PubMed ID: 6171038
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. The role of radionuclide bone-scanning in determining the resectability of soft-tissue sarcomas.
Enneking WF; Chew FS; Springfield DS; Hudson TM; Spanier SS
J Bone Joint Surg Am; 1981 Feb; 63(2):249-57. PubMed ID: 7462282
[TBL] [Abstract][Full Text] [Related]
4. The comparative value of bone scintigraphy and computed tomography in determining bone involvement by soft-tissue sarcomas.
Hudson TM; Schakel M; Springfield DS; Spanier SS; Enneking WF
J Bone Joint Surg Am; 1984 Dec; 66(9):1400-7. PubMed ID: 6501336
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities.
Kirchner PT; Simon MA
J Bone Joint Surg Am; 1984 Mar; 66(3):319-27. PubMed ID: 6230363
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
[TBL] [Abstract][Full Text] [Related]
7. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Tc-99m pertechnetate with Tl-201 and Ga-67 scintigraphy of malignant soft-tissue tumors.
Abe H; Terui S; Terauchi T; Muramatsu Y; Yokayama R; Ohtomo K; Beppu Y; Fukuma H
Clin Nucl Med; 1997 Jan; 22(1):38-41. PubMed ID: 8993872
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors.
Edeling CJ
Nuklearmedizin; 1982 Aug; 21(4):136-9. PubMed ID: 6959075
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.
Simon MA; Kirchner PT
J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of tumor scintigraphy with 99mTc-bleomycin. (Part II). Combined studies of tumor scintigraphy with 99mTc-BLM and 67Ga-citrate, bone scintigraphy and angiography in bone and soft tissue tumors (author's transl)].
Odori T
Kaku Igaku; 1979 Sep; 16(6):829-47. PubMed ID: 93151
[No Abstract] [Full Text] [Related]
12. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
13. Gallium scans in Paget's sarcoma.
Yeh SD; Rosen G; Benua RS
Clin Nucl Med; 1982 Dec; 7(12):546-52. PubMed ID: 6959752
[TBL] [Abstract][Full Text] [Related]
14. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
15. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
[TBL] [Abstract][Full Text] [Related]
16. Detection of malignant soft tissue tumors in bone imaging.
Vorne M; Saukko T
Eur J Nucl Med; 1984; 9(4):180-4. PubMed ID: 6325202
[TBL] [Abstract][Full Text] [Related]
17. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
18. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
[TBL] [Abstract][Full Text] [Related]
19. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic evaluation of giant cell tumor of bone.
Levine E; De Smet AA; Neff JR; Martin NL
AJR Am J Roentgenol; 1984 Aug; 143(2):343-8. PubMed ID: 6234786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
